|
Real-time Estimate
Cboe BZX
19:53:53 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.155 USD | +1.32% |
|
-0.85% | -13.97% |
| 08-14 | Actinium Pharmaceuticals Expands Manufacturing Capacity for Actimab-A Program | CI |
| 08-14 | Actinium Pharmaceuticals, Inc. Amends Its Investigational New Drug | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.32% | -0.85% | +14.71% | +19.39% | -13.97% | -26.88% | -79.11% | -86.79% | -97.11% | 35.84M | |
| +4.16% | -0.30% | +6.32% | +32.63% | +84.62% | +58.96% | +94.17% | +11.49% | - | 71.53B | |
| -0.19% | +1.32% | -3.29% | +4.36% | +18.14% | +37.20% | +81.33% | +226.32% | +5,434.64% | 60.12B | |
| -1.51% | +2.39% | -0.24% | +5.39% | +6.95% | +9.10% | +36.79% | -18.02% | +209.91% | 48.85B | |
| +0.56% | +1.09% | +3.68% | +40.15% | +20.13% | +42.57% | +39.67% | +13.05% | +234.06% | 44.28B | |
| +0.82% | +8.47% | +0.64% | +10.47% | +159.75% | +343.02% | +690.57% | +652.06% | - | 43.83B | |
| +1.31% | +1.52% | +3.05% | +30.03% | +21.97% | +8.76% | +107.59% | +2.08% | +1,102.69% | 41.53B | |
| -0.67% | -0.45% | -6.82% | -0.84% | +3.09% | +4.47% | +46.37% | -17.19% | +134.15% | 30.13B | |
| +4.77% | +6.46% | +10.66% | +58.87% | +78.28% | +41.54% | +22.78% | -55.45% | - | 27.98B | |
| -0.33% | -2.15% | -4.95% | +8.60% | -33.47% | -19.60% | +356.41% | +320.44% | +697.45% | 25.25B | |
| +0.09% | +0.34% | -2.78% | +6.17% | +3.77% | +0.17% | -12.38% | -63.81% | - | 24.76B | |
| +1.12% | +2.23% | +10.41% | +30.53% | +15.59% | +21.56% | -4.13% | -16.59% | +107.35% | 20.99B | |
| +0.52% | +1.40% | +5.36% | +18.17% | +11.42% | +21.72% | +158.00% | +230.63% | +1,995.83% | 17.36B | |
| +1.67% | +4.74% | -21.36% | +6.12% | +186.76% | +163.24% | +345.14% | +1,419.98% | +651.59% | 15.54B | |
| -1.57% | -1.52% | +3.39% | +9.39% | +20.19% | +21.40% | +43.29% | -32.33% | +85.48% | 14.99B | |
| +0.30% | +2.77% | -12.82% | -14.02% | - | - | - | - | - | 14.98B | |
| +1.05% | +9.39% | +32.89% | +44.63% | +41.89% | +3.81% | - | - | - | 14.9B | |
| +0.64% | +4.72% | +8.73% | +9.19% | +35.55% | +43.85% | +167.37% | +181.03% | +364.50% | 14.53B | |
| +2.96% | -0.65% | -5.34% | +11.80% | +24.17% | -1.74% | +535.77% | - | - | 14.41B | |
| +0.30% | +7.18% | +3.12% | +31.06% | +49.01% | +89.98% | +53.70% | -27.97% | +256.66% | 14.13B | |
| Average | +0.93% | +0.31% | +2.27% | +18.10% | +38.62% | +45.43% | +149.07% | +161.11% | +859.79% | 28.01B | |
| Weighted average by Cap. | +1.01% | +0.51% | +1.57% | +19.15% | +43.53% | +56.16% | +151.29% | +144.82% | +1,357.46% |
- Stock Market
- Stocks
- ATNM Stock
- Sector Actinium Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
